ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
2,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
3,1,Anterior chamber inflammation,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
3,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
3,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
4,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
4,3,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
6,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Corneal graft rejection,Transplant rejections,Immune disorders NEC,Immun,N
9,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10,1,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
11,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
